Magnesium

Disclaimer: The information presented in this section is for educational and informational purposes only. It is not intended as medical advice. No supplement discussed on this site has been proven to prevent, stop, or reverse neurodegenerative disease. While some supplements have been studied for their potential to support aspects of cellular function, any observed effects are generally modest, variable between individuals, and highly context-dependent. Before starting any supplement, consult with a qualified healthcare professional. Appropriate professionals may include a physician, neurologist, pharmacist, nurse practitioner, physician assistant, or registered dietitian. This does not refer to wellness influencers, supplement sellers, health coaches, or practitioners without medical training in pharmacology, neurology, and drug-supplement interactions. Supplements may interact with medications or produce unintended side effects. The inclusion of any supplement on this site does not constitute a recommendation for use. Descriptions of mechanisms or research findings are provided to improve understanding of current scientific investigation, not to guide individual treatment decisions.

Overview

Magnesium is an essential mineral involved in neuronal excitability, energy metabolism, vascular tone, and synaptic signaling. In the brain-health space, magnesium is often marketed for memory, sleep, mood, and dementia prevention, with particular recent interest in magnesium threonate and magnesium glycinate formulations.

Magnesium is important for general physiology, but not clearly established as a neurodegeneration supplement. The biology is plausible, especially for sleep, vascular health, and neuronal signaling, but the direct dementia or disease-modifying evidence is weak.

Proposed Mechanisms

Proposed mechanisms include effects on NMDA receptor-related signaling, neuronal excitability, vascular function, and possibly inflammatory or metabolic pathways. Because magnesium status influences several systems relevant to brain function, it is easy to make it sound broadly neuroprotective.

But as with vitamin D, association does not prove that supplementation will alter disease course. Low magnesium may sometimes mark broader illness, nutritional issues, or other risk factors rather than being the primary driver.

Evidence Summary

Preclinical: Preclinical and mechanistic work supports the idea that magnesium can influence cognition-related pathways, but the translational bridge remains weak. The broad biologic rationale is stronger than the definitive in vivo neurodegeneration trial evidence.

Translational / RCT / observational: A 2024 systematic review and meta-analysis found insufficient randomized control trial data to draw firm conclusions about magnesium supplementation and cognitive outcomes, with several trials at high risk of bias. Some newer work on magnesium L-threonate suggests possible cognitive effects in older adults with mild cognitive impairment, but these data are still limited and not enough to establish the category.

Evidence level

Low overall.

Magnesium is biologically relevant and correcting deficiency is sensible general care, but the evidence does not support strong claims that magnesium supplementation broadly prevents or slows neurodegeneration.

Limitations

The literature is limited by few high-quality randomized trials, variable formulations, and uncertainty about whether serum magnesium meaningfully reflects brain magnesium status. This is an area where marketing often runs much farther than the evidence.

Safety and Considerations

Magnesium is generally safe at reasonable doses, but diarrhea and GI effects are common, and renal impairment changes the safety picture.

Sources

Chen F et al. “Magnesium and Cognitive Health in Adults: A Systematic Review and Meta-Analysis.” 2024.
Varga P et al. “The Role of Magnesium in Depression, Migraine, Alzheimer’s Disease…” 2025.
Patel V et al. “Neuroprotective effects of magnesium: implications for Alzheimer’s disease.” 2024.